top of page
CLINICAL TRIALS​
International CIPN Assessment and Validation Study (ICAVS)
NCT04633655
PATENTS
Tumor Agnostic Drug Delivery with Self-Agglomerating Nanohydrogels
Housley et al.
Application No. PCT/US2024/040745
Combination Therapeutics for Treatment of Proliferative Disorders
Housley et al.
Application No. 18/271,926
Inline Manipulation of Cells and Cell Clusters
Boya et al.
Application No. PCT/US2023/082980
Start Ups
OnCuRNA
At OnCuRNA, our novel nanohydrogel system (SANGs) enhances the delivery of therapeutic payloads to solid tumors, offering unprecedented control over drug release, targeting, and efficacy.
bottom of page